To request a trial to The Deal Pipeline, please click here or contact Michael Crosby, Vice President of Sales, at 212-313-9325.


Be wary of a Genzyme purchase

by Kenneth Bredemeier
A 'measured and thoughtful' assessment of Sanofi's (NYSE:SNY) potential acquisition of Genzyme (NASDAQ:GENZ).   More


Newcomers face cost of capital challenge

The dearth of midmarket lenders has made way for new entrants, says Randy Schwimmer, head of capital markets at Churchill Financial Holdings LLC.


©Copyright 2010, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.